Insider Selling: Rapid Micro Biosystems (NASDAQ:RPID) COO Sells 4,610 Shares of Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) COO John Addington Wilson sold 4,610 shares of the firm’s stock in a transaction on Monday, February 9th. The shares were sold at an average price of $3.78, for a total value of $17,425.80. Following the completion of the sale, the chief operating officer directly owned 257,768 shares in the company, valued at approximately $974,363.04. This represents a 1.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Rapid Micro Biosystems Price Performance

NASDAQ:RPID traded up $0.33 during trading hours on Tuesday, hitting $4.08. The company’s stock had a trading volume of 306,371 shares, compared to its average volume of 371,737. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.23 and a quick ratio of 2.95. The company has a market capitalization of $180.83 million, a P/E ratio of -4.04 and a beta of 1.38. Rapid Micro Biosystems, Inc. has a twelve month low of $1.86 and a twelve month high of $4.94. The stock has a fifty day simple moving average of $3.66 and a 200-day simple moving average of $3.39.

Rapid Micro Biosystems (NASDAQ:RPID) last posted its quarterly earnings data on Friday, November 7th. The company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26). Rapid Micro Biosystems had a negative net margin of 145.11% and a negative return on equity of 73.90%. The company had revenue of $7.84 million during the quarter, compared to analysts’ expectations of $7.60 million. On average, analysts anticipate that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on RPID. Wall Street Zen cut Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research report on Saturday, January 17th. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Rapid Micro Biosystems has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of RPID. Evernest Financial Advisors LLC lifted its stake in shares of Rapid Micro Biosystems by 355.1% during the 3rd quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock worth $669,000 after acquiring an additional 156,234 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Rapid Micro Biosystems by 6.7% in the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after purchasing an additional 60,655 shares in the last quarter. Goldman Sachs Group Inc. purchased a new stake in shares of Rapid Micro Biosystems in the 4th quarter worth approximately $160,000. XTX Topco Ltd purchased a new position in shares of Rapid Micro Biosystems in the 2nd quarter valued at $144,000. Finally, Nano Cap New Millennium Growth Fund L P purchased a new stake in shares of Rapid Micro Biosystems in the 4th quarter valued at $72,000. 52.60% of the stock is owned by hedge funds and other institutional investors.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.